ClinicalTrials.gov record
Completed Phase 1 Interventional

A Safety Study of SGN-LIV1A in Breast Cancer Patients

ClinicalTrials.gov ID: NCT01969643

Public ClinicalTrials.gov record NCT01969643. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 12, 2026, 7:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1, Open-Label, Dose-Escalation Study to Evaluate the Safety and Tolerability of SGN-LIV1A in Patients With Metastatic Breast Cancer

Study identification

NCT ID
NCT01969643
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Seagen Inc.
Industry
Enrollment
290 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 21, 2013
Primary completion
Feb 3, 2023
Completion
Feb 3, 2023
Last update posted
Mar 6, 2023

2013 – 2023

United States locations

U.S. sites
38
U.S. states
25
U.S. cities
33
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35249
Pinnacle Oncology Hematology Scottsdale Arizona 85258
UC San Diego / Moores Cancer Center La Jolla California 92093
Cedars Sinai Medical Center / Samuel Oschin Comprehensive Cancer Institute Los Angeles California 90048
University of California at San Francisco San Francisco California 94134
UCLA Medical Center / David Geffen School of Medicine Santa Monica California 90404
Rocky Mountain Cancer Centers - Aurora Aurora Colorado 80012
Poudre Valley Health System (PVHS) Fort Collins Colorado 80528
Yale Cancer Center New Haven Connecticut 06520
The Whittingham Cancer Center / Norwalk Hospital Norwalk Connecticut 06856
H. Lee Moffitt Cancer Center and Research Institute Tampa Florida 33612
Piedmont Cancer Institute Atlanta Georgia 30309
University of Chicago Medical Center Chicago Illinois 60637
Indiana University Simon Cancer Center Indianapolis Indiana 46202
Louisiana State University Health Sciences Center New Orleans Louisiana 70112
University of Maryland Baltimore Maryland 21201
Dana Farber Cancer Institute Boston Massachusetts 02215
Karmanos Cancer Institute / Wayne State University Detroit Michigan 48201
Allina Health Cancer Institute Minneapolis Minnesota 55407
University of Minnesota Minneapolis Minnesota 55455
Mayo Clinic Rochester Rochester Minnesota 55905
Washington University in St Louis St Louis Missouri 63110
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89169
University of New Mexico Cancer Center Albuquerque New Mexico 87131
Columbia University Medical Center New York New York 10032
Memorial Sloan Kettering Cancer Center New York New York 10065
Weill Cornell Medicine New York New York 10065
Wake Forest Baptist Medical Center / Wake Forest University Winston-Salem North Carolina 27157
Case Western Reserve University / University Hospitals Cleveland Medical Center Cleveland Ohio 44106
The Cleveland Clinic Cleveland Ohio 44195
Oregon Health and Science University Portland Oregon 97239
Tennessee Oncology-Nashville/Sarah Cannon Research Institute Nashville Tennessee 37203
Texas Oncology - Baylor Sammons Cancer Center Dallas Texas 75246
Cancer Care Centers of South Texas - HOAST/Texas Oncology New Braunfels Texas 78130
Northwest Medical Specialties Puyallup Washington 98373
Swedish Cancer Institute Seattle Washington 98104
Seattle Cancer Care Alliance / University of Washington Seattle Washington 98109
West Virginia University Morgantown West Virginia 26506

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01969643, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 6, 2023 · Synced May 12, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01969643 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →